Suchergebnisse - "Enomoto, Takayuki"

PubPharm (21)

1

Efficacy and safety of standard of care with/without bevacizumab for platinum-resistant ovarian/fallopian tube/peritoneal cancer previously treated with bevacizumab : The Japanese Gynecologic Oncology Group study JGOG3023

enthalten in: Cancer science | 2022

von Shoji, T. | Enomoto, T. | Abe, M. | +10

2

MCM10 compensates for Myc-induced DNA replication stress in breast cancer stem-like cells

enthalten in: Cancer science | 2021

von Murayama, T. | Takeuchi, Y. | Yamawaki, K. | +24

3

Trends and characteristics of epithelial ovarian cancer in Japan between 2002 and 2015 : A JSGO-JSOG joint study

enthalten in: Gynecologic oncology | 2019

von Machida, H. | Matsuo, K. | Yamagami, W. | +7

4

Asian Society of Gynecologic Oncology International Workshop 2018

enthalten in: Journal of gynecologic oncology | 2019

von Kong, T. | Ryu, H. | Kim, S. | +38

5

Olaparib tablets as maintenance therapy in patients with platinum-sensitive, relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21) : a double-blind, randomised, placebo-controlled, phase 3 trial

enthalten in: The Lancet. Oncology | 2017

von Pujade-Lauraine, E. | Ledermann, J. | Selle, F. | +118

CommentIn: Lancet Oncol. 2017 Sep;18(9):1151-1152. - PMID 28754484

6

Establishment of a Novel Histopathological Classification of High-Grade Serous Ovarian Carcinoma Correlated with Prognostically Distinct Gene Expression Subtypes

enthalten in: The American journal of pathology | 2016

von Murakami, R. | Matsumura, N. | Mandai, M. | +17

7

CpG oligodeoxynucleotides potentiate the antitumor activity of anti-BST2 antibody

enthalten in: Cancer science | 2015

von Hiramatsu, K. | Serada, S. | Kobiyama, K. | +10

8

Annexin A4 induces platinum resistance in a chloride-and calcium-dependent manner

enthalten in: Oncotarget | 2014

von Morimoto, A. | Serada, S. | Enomoto, T. | +9

9

Annexin A4-conferred platinum resistance is mediated by the copper transporter ATP7A

enthalten in: International journal of cancer | 2014

von Matsuzaki, S. | Enomoto, T. | Serada, S. | +12

10

A phase II study of combination chemotherapy using docetaxel and irinotecan for TC-refractory or TC-resistant ovarian carcinomas (GOGO-OV2 study) and for primary clear or mucinous ovarian carcinomas (GOGO-OV3 Study)

enthalten in: European journal of obstetrics, gynecology, and reproductive biology | 2013

von Ueda, Y. | Miyatake, T. | Nagamatsu, M. | +7